Adaptation to Stress: Biofilms and Small-Colony Variants

Staphylococci in Human Disease: Second Edition

Volumn , Issue , 2009, Pages 109-124

  Thompson, Karl M ^a   Jefferson, Kimberly K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Biofilm clinical implications; Biofilm determinants intercellular adhesin locus; Biofilms and small colony variants; Global regulation in small colony variants and SigB role; Immune defense resistance; Mobile genetic elements and biofilm formation; Proteinaceous biofilm adhesins; Small colony variants and pathogenesis and intracellular persistence; Staphylococcus aureus and surface protein G; Stress response

Indexed keywords

EID: 84890576942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444308464.ch5     Document Type: Chapter

References (158)

1. Shanks RM, Donegan NP, Graber ML et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005; 73:4596-606.
2. Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21:2247-55.
3. Cramton SE, Ulrich M, Götz F, Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 2001;69:4079- 85.
4. Lim Y, Jana M, Luong TT, Lee CY. Control of glucose and NaCl-induced biofilm formation by rbf in Staphylococcus aureus. J Bacteriol 2004;186:722-9.
5. Resch A, Rosenstein R, Nerz C, Gotz F. Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic condition. Appl Environ Microbiol 2005;71:2663-76.
6. Beenken KE, Dunman PM, McAleese F et al. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 2004; 186:4665-84.
7. George EA, Muir TW. Molecular mechanisms of agr quorum sensing in virulent staphylococci. Chembiochem 2007;8:847-55.
8. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002; 56:187-209.
9. Foster SJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998;6:484-8.
10. Mack D, Fischer W, Krokotsch A et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996;178:175-83.
11. Maira-Litràn T, Kropec A, Abeygunawardana C et al. Immunochemical properties of the staphylococcal poly-Nacetylglucosamine surface polysaccharide. Infect Immun 2002; 70:4433-40.
12. Roche FM, Massey R, Peacock SJ et al. Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology 2003;149:643-54.
13. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 2007;153:2435-46.
14. Frank KL, Patel R. Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates. Infect Immun 2007;75:4728-42.
15. Rohde H, Burandt EC, Siemssen N et al. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007;28:1711-20.
16. Hennig S, Nyunt Wai S, Ziebuhr W. Spontaneous switch to PIAindependent biofilm formation in an ica-positive Staphylococcus epidermidis isolate. Int J Med Microbiol 2007;297:117-22.
17. Qin Z, Ou Y, Yang L et al. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology 2007;153:2083-92.
18. Stoodley P, Wilson S, Hall-Stoodley L, Boyle JD, Lappin-Scott HM, Costerton JW. Growth and detachment of cell clusters from mature mixed species biofilms. Appl Environ Microbiol 2001;67:5608-13.
19. Cramton SE, Gerke C, Schnell NF, Nichols WW, Götz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999;67:5427-33.
20. Gerke C, Kraft A, Sussmuth R, Schweitzer O, Götz F. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem 1998;273: 18586-93.
21. Götz F. Staphylococcus and biofilms. Mol Microbiol 2002;43: 1367-78.
22. Vuong C, Kocianova S, Voyich JM et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 2004;279:54881-6.
23. Maira-Litran T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 2005;73:6752-62.
24. Conlon KM, Humphreys H, O'Gara JP. icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J Bacteriol 2002;184:4400-8.
25. Jefferson KK, Cramton SE, Gotz F, Pier GB. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNAbinding properties of IcaR. Mol Microbiol 2003;48:889-99.
26. Conlon KM, Humphreys H, O'Gara JP. Regulation of icaR gene expression in Staphylococcus epidermidis. FEMS Microbiol Lett 2002;216:171-7.
27. Jefferson KK, Pier DB, Goldmann DA, Pier GB. The teicoplaninassociated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol 2004;186:2449-56.
28. Ziebuhr W, Krimmer V, Rachid S, Lossner I, Götz F, Hacker J. A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol 1999;32:345-56.
29. Kiem S, Oh WS, Peck KR et al. Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface. J Korean Med Sci 2004;19:779-82.
30. Rechtin TM, Gillaspy AF, Schumacher MA, Brennan RG, Smeltzer MS, Hurlburt BK. Characterization of the SarA virulence gene regulator of Staphylococcus aureus. Mol Microbiol 1999;33:307-16.
31. Handke LD, Slater SR, Conlon KM et al. SigmaB and SarA independently regulate polysaccharide intercellular adhesin production in Staphylococcus epidermidis. Can J Microbiol 2007; 53:82-91.
32. Valle J, Toledo-Arana A, Berasain C et al. SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 2003;48:1075-87.
33. Sterba KM, Mackintosh SG, Blevins JS, Hurlburt BK, Smeltzer MS. Characterization of Staphylococcus aureus SarA binding sites. J Bacteriol 2003;185:4410-17.
34. Wu S, de Lencastre H, Tomaz A. Sigma-B, a putative operon encoding alternative sigma factor of Staphylococcus aureusRNA polymerase: molecular cloning and DNA sequencing. J Bacteriol 1996;178:6036-42.
35. Morikawa K, Inose Y, Okamura H et al. A new staphylococcal sigma factor in the conserved gene cassette: functional significance and implication for the evolutionary processes. Genes Cells 2003;8:699-712.
36. Rachid S, Ohlsen K, Wallner U, Hacker J, Hecker M, Ziebuhr W. Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol 2000;182:6824-6.
37. Knobloch JK, Bartscht K, Sabottke A, Rohde H, Feucht HH, Mack D. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J Bacteriol 2001;183:2624-33.
38. Bateman BT, Donegan NP, Jarry TM, Palma M, Cheung AL. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect Immun 2001;69:7851-7.
39. Knobloch JK, Jager S, Horstkotte MA, Rohde H, Mack D. RsbUdependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by repression of the negative regulator gene icaR. Infect Immun 2004;72:3838-48.
40. Kies S, Otto M, Vuong C, Gotz F. Identification of the sigB operon in Staphylococcus epidermidis: construction and characterization of a sigB deletion mutant. Infect Immun 2001;69:7933-6.
41. Sadykov MR, Olson ME, Halouska S et al. Tricarboxylic acid cycle-dependent regulation of Staphylococcus epidermidis polysaccharide intercellular adhesin synthesis. J Bacteriol 2008;190: 7621-32.
42. Dobinsky S, Kiel K, Rohde H et al. Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J Bacteriol 2003;185:2879-86.
43. Seidl K, Goerke C, Wolz C, Mack D, Berger-Bachi B, Bischoff M. Staphylococcus aureus CcpA affects biofilm formation. Infect Immun 2008;76:2044-50.
44. Frees D, Chastanet A, Qazi SN et al. Clp ATPases are required for stress tolerance, intracellular replication and biofilm formation in Staphylococcus aureus. Mol Microbiol 2004;54:1445-62.
45. Trotonda MP, Tamber S, Memmi G, Cheung AL. MgrA represses biofilm formation in Staphylococcus aureus. Infect Immun 2008;76:5645-54.
46. Latasa C, Solano C, Penadés JR, Lasa I. Biofilm-associated proteins. C R Biol 2006;329:849-57.
47. Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penades JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 2001;183:2888-96.
48. Cucarella C, Tormo MA, Knecht E et al. Expression of the biofilm-associated protein interferes with host protein receptors of Staphylococcus aureus and alters the infective process. Infect Immun 2002;70:3180-6.
49. Cucarella C, Tormo MA, Ubeda C et al. Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus. Infect Immun 2004;72:2177-85.
50. Trotonda MP, Manna AC, Cheung AL, Lasa I, Penades JR. SarA positively controls bap-dependent biofilm formation in Staphylococcus aureus. J Bacteriol 2005;187:5790-8.
51. Arrizubieta MJ, Toledo-Arana A, Amorena B, Penades JR, Lasa I. Calcium inhibits bap-dependent multicellular behavior in Staphylococcus aureus. J Bacteriol 2004;186:7490-8.
52. Kretsinger RH, Nockolds CE. Carp muscle calcium-binding protein. II. Structure determination and general description. J Biol Chem 1973;248:3313-26.
53. Schumacher-Perdreau F, Heilmann C, Peters G, Gotz F, Pulverer G. Comparaive analysis of a biofilm forming Staphylococcus epidermidis strain and its adhesion-positive, accumulationnegative isogenic mutant. FEMS Microbiol Lett 1994;117:71-8.
54. Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun 1997;65:519-24.
55. Sun D, Accavitti MA, Bryers JD. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol 2005;12:93-100.
56. Roche FM, Meehan M, Foster TJ. The Staphylococcus aureus surfaces protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 2003;149:2759-67.
57. Kuroda M, Ito R, Tanaka Y et al. Staphylococcus aureus surface protein SasG contributes to intercellular autoaggregation of Staphylococcus aureus. Biochem Biophys Res Commun 2008; 377:1102-6.
58. Heilmann C, Hussain M, Peters G, Gotz F. Evidence for autolysinmediated primary attachment of Staphylococcus epidermidis to polystyrene surface. Mol Microbiol 1997;24:1013-24.
59. Hell W, Meyer HG, Gaterman SG. Cloning of aas, a gene encoding a Staphylococcus saprophyticus surface protein with adhesive and autolytic properties. Mol Microbiol 1998;29:871-81.
60. van der Woude MW, Baumler AJ. Phase and antigenic variation in bacteria. Clin Microbiol Rev 2004;17:581-611.
61. Conlon KM, Humphreys H, O'Gara JP. Inactivations of rsbU and sarA by IS256 represent novel mechanisms of biofilm phenotypic variation in Staphylococcus epidermidis. J Bacteriol 2004;186:6208-19.
62. Tormo MA, Ubeda C, Marti M et al. Phase-variable expression of the biofilm-associated protein (Bap) in Staphylococcus aureus. Microbiology 2007;153:1702-10.
63. Ubeda C, Tormo MA, Cucarella C et al. Sip, an integrase protein with excision, circularization and integration activities, defines a new family of mobile Staphylococcus aureus pathogenicity islands. Mol Microbiol 2003;49:193-210.
64. Redfield RJ. Is quorum sensing a side effect of diffusion sensing? Trends Microbiol 2002;10:365-70.
65. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001;55:165-99.
66. Kong KF, Vuong C, Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol 2006;296:133-9.
67. Otto M, Sussmuth R, Jung G, Gotz F. Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett 1998;424:89-94.
68. Otto M. Staphylococcus aureus and Staphylococcus epidermidis peptide pheromones produced by the accessory gene regulator agr system. Peptides 2001;22:1603-8.
69. Novick RP, Muir TW. Virulence gene regulation by peptides in staphylococci and other gram-positive bacteria. Curr Opin Microbiol 1999;2:40-5.
70. Lina G, Jarraud S, Ji G et al. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol Microbiol 1998;28:655-62.
71. Janson L, Arvidson S. The role of the d-lysin (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J 1990;9:1391-9.
72. Boisset S, Geissmann T, Huntzinger E et al. Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev 2007;21:1351-66.
73. Geisinger E, Adhikari RP, Jin R, Ross HF, Novick RP. Inhibition of rot translation by RNAIII, a key feature of agr function. Mol Microbiol 2006;61:1038-48.
74. Huntzinger E, Boisset S, Saveanu C et al. Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression. EMBO J 2005;24:824-35.
75. Balaban N. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating peptide protein (TraP). J Biol Chem 2001;276:2658-67.
76. Adhikari RP, Arvidson S, Novick RP. A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP:kan. Infect Immun 2007;75:4534-50.
77. Tsang LH, Daily ST, Weiss EC, Smeltzer MS. Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation. Infect Immun 2007;75:4528-33.
78. Otto M. Quorum-sensing control in staphylococci: a target for antimicrobial drug therapy? FEMS Microbiol Lett 2004; 241:135-41.
79. Vuong C, Saenz HL, Gotz F, Otto M. Impact of the agr quorumsensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 2000;182:1688-93.
80. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003;188:706-18.
81. Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. Increased colonization of indwelling medical devices by quorumsensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis 2004;190:1498-505.
82. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004;186:1838-50.
83. Coelho LR, Souza RR, Ferreira FA, Guimaraes MA, Ferreira- Carvalho BT, Figueiredo AM. agr RNAIII divergently regulates glucose-induced biofilm formation in clinical isolates of Staphylococcus aureus. Microbiology 2008;154:3480-90.
84. Winzer K, Hardie KR, Burgess N et al. LuxS: its role in central metabolism and the in vitro synthesis of 4-hydroxy-5-methyl- 3(2H)-furanone. Microbiology 2002;148:909-22.
85. Xu L, Li H, Vuong C et al. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect Immun 2006;74:488-96.
86. Doherty N, Holden MTG, Qazi SN, Williams P, Winzer K. Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. Infect Immun 2006;188:2885-97.
87. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science 2006;311:1113-16.
88. Cotter PA, Stibitz S. c-di-GMP-mediated regulation of virulence and biofilm formation. Curr Opin Microbiol 2007;10: 17-23.
89. Tamayo R, Pratt JT, Camilli A. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu Rev Microbiol 2007;61:131-48.
90. Tischler AD, Camilli A. Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol Microbiol 2004; 53:857-69.
91. Karaolis DK, Rashid MH, Chythanya R, Luo W, Hyodo M, Hayakawa Y. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interacterions and biofilm. Antimicrob Agents Chemother 2005;49:1029-38.
92. Brouillette E, Hyodo M, Hayakawa Y, Karaolis DK, Malouin F. 3',5'-Cyclic diguanylic acid reduces the virulence of biofilmforming Staphylococcus aureus strains in a mouse model of mastitis infection. Antimicrob Agents Chemother 2005;49:3109 -13.
93. Lee VT, Matewish JM, Kessler JL, Hyodo M, Hayakawa Y. A cyclic-di-GMP receptor required for bacterial exopolysaccharide production. Mol Microbiol 2007;65:1474-84.
94. Karaolis DK, Means TK, Yand D et al. Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol 2007;178:2171-81.
95. Resch A, Fehrenbacher B, Eisele K, Schaller M, Gotz F. Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol Lett 2005;252:89-96.
96. Cerca N, Oliveira R, Azeredo J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett Appl Microbiol 2007; 45:313-17.
97. Summers WC. Bacteriophage therapy. Annu Rev Microbiol 2001;55:437-51.
98. Fishetti VA, Nelson D, Schuch R. Reinventing phage therapy: are the parts greater than the sum? Nat Biotechnol 2006; 24:1508-11.
99. Curtin JJ, Donlan RM. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 2006;50:1268-75.
100. Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002;70:6339-45.
101. O'Toole GA, Stewart PS. Biofilms strike back. Nat Biotechnol 2005;23:1378-9.
102. Houari A, Di Martino P. Effect of chlorhexidine and benzalkonium chloride on bacterial biofilm formation. Lett Appl Microbiol 2007;45:652-6.
103. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34-40.
104. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000;44:1818-24.
105. Raad I, Hanna H, Jiang Y et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007;51:1656-60.
106. Monzon M, Oteiza C, Leiva J, Lamata M, Amorena B. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 2002;44:319-24.
107. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2002;46:900-3.
108. Stewart PS. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother 1996;40:2517-22.
109. Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 2005;49:2467- 73.
110. Bigger JW. Treatment of staphylococcal infections with penicillin. Lancet 1944;244:497- 500.
111. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005;70:267-74.
112. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 2004;230:13-18.
113. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007;5:48-56.
114. De Kievit TR, Parkins MD, Gillis RJ et al. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2001;45:1761-70.
115. Vuong C, Voyich JM, Fischer ER et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004;6:269-75.
116. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 2006;74:4849-55.
117. Begun J, Gaiani JM, Rohde H et al. Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog 2007;3:e57.
118. Balaban N, Gov Y, Bitler A, Boelaert JR. Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int 2003;63:340-5.
119. Balaban N, Giacometti A, Cirioni O et al. Use of the quorumsensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 2003;187:625-30.
120. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 2005;(437):48-54.
121. Baveja JK, Willcox MD, Hume EB, Kumar N, Odell R, Poole- Warren LA. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials 2004;25:5003-12.
122. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 2007;51:78- 83.
123. Donelli G, Francolini I, Romoli D et al. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 2007;51:2733-40.
124. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003;47:3407-14.
125. Samuelsen O, Haukland HH, Kahl B et al. Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J Antimicrob Chemother 2005;56:1126- 9.
126. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang A, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005;436:1171-5.
127. Deziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol 2001;183:1195-204.
128. Haussler S. Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. Environ Microbiol 2004;6:546-51.
129. Neut D, Van Der Mei HC, Bulstra SK, Busscher HJ. The role of small colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 2007;78:299.
130. Proctor RA, von Eiff C, Kahl BC et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006;4:295-305.
131. von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept: the role of staphylococcal SCVs in persistent infections. Injury 2006;37:S26-S33.
132. Eisenberg P. Untersuchungen uber die variablen Typhusstamm (Bacterium typhi mutabile), sowie uber eine eigentumliche hemmende Wirkung des gewohnlichen Agar, verursacht durch Autoklavierung, abstr. 56. Zentbl Bakteriol Abt 1910;1:208.
133. Swingle EL. Studies on small colony variants of Staphylococcus aureus. J Bacteriol 1935;29:467-89.
134. Kahl B, Herrmann M, Everding AS et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998;177:1023-9.
135. Besier S, Smaczny C, von Mallinckrodt C et al. Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol 2007;45:168-72.
136. Chatterjee I, Kriegeskorte A, Fischer A et al. In vivo mutations of thymidylate synthase (thyA) are responsible for thymidine dependency in clinical small colony variants (TD-SCVs) of Staphylococcus aureus. J Bacteriol 2008;190:834-42.
137. Besier S, Ludwig A, Ohlsen K, Brade V, Wichelhaus TA. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol 2007;297:217-25.
138. Saxild HH, Anderon LN, Hammer K. dra-nupC-pdp operon of Bacillus subtilis: nucleotide sequence, induction by deoxyribonucleosides, and transcriptional regulation by the deoRencoded DeoR repressor protein. J Bacteriol 1996;178:424-34.
139. Schaaff F, Bierbaum G, Baumert N, Bartmann P, Sahl H-G. Mutations are involved in emergence of aminoglycosideinduced small colony variants of Staphylococcus aureus. Int J Med Microbiol 2003;293:427-35.
140. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistant and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995;20:95-102.
141. Balwit JM, van Langevelde P, Vann JM, Proctor RA. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis 1994;170:1033-7.
142. Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM, Proctor RA. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis 1996; 173:739-42.
143. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Gotz F. A site-directed Staphylococcus aureus hemB mutant is a smallcolony variant which persists intracellularly. J Bacteriol 1997; 179:4706-12.
144. von Eiff C, Becker K, Metze D et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin Infect Dis 2001;32:1643-7.
145. Vaudaux P, Francois P, Bisognano C et al. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun 2002;70:5428-37.
146. Brouillette E, Martinez A, Boyll BJ, Allen NE, Malouin F. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol Med Microbiol 2004;41:35-41.
147. Senn MM, Bischoff M, von Eiff C, Berger-Bachi B. sB activity in a Staphylococcus aureus hemB mutant. J Bacteriol 2005; 187:7397-406.
148. Moisan H, Brouillette E, Jacob CL, Langlois-Begin P, Michaud S, Malouin F. Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol 2006;188:64-76.
149. Malouin F, Brouillette E, Martinez RM et al. Identification of antimicrobial compounds active against intracellular Staphylococcus aureus. FEMS Immunol Med Microbiol 2005;45:245- 52.
150. Miller MM, Wexler MA, Steigbigel NH. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother 1978;14:336-43.
151. Pelleter LL Jr, Richardson M, Feist M. Virulent gentamicininduced small colony variants of Staphylococcus aureus. J Lab Clin Med 1979;94:324-34.
152. Bulger RJ, Bulger RE. Ultrastructure of small colony variants of a methicillin-resistant Staphylococcus aureus. J Bacteriol 1969; 94:1244-6.
153. Bulger RJ. In vitro studies on highly resistant small colony variants of Staphylococcus aureus resistant to methicillin. J Infect Dis 1969;120:491-4.
154. Adler H, Widmer A, Frei R. Emergence of a teicoplaninresistant small colony variant of Staphylococcus epidermidis during vancomycin therapy. Eur J Clin Microbiol Infect Dis 2003;22:746-8.
155. Seaman PF, Ochs D, Day MJ. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2007;59:43-50.
156. Bayston R, Ashraf W, Smith S. Triclosan resistance in methicillin- resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 2007;59:848-53.
157. Mitsuyama J, Yamada H, Maehana J et al. Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. J Antimicrob Chemother 1997;39:697-705.
158. Kahl B, Belling G, Becker P et al. Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect Immun 2005;73:4119-26.